This program will provide an overview of the burden and progression of COPD, discuss the current rationale supporting evidence-based treatment, and present key clinical data for Perforomist® (formoterol fumarate) Inhalation Solution in the treatment of COPD.
Professor of Medicine
University of Texas Health Science Center at San Antonio
Section Chief, Pulmonary/Critical Care
South Texas Veterans Health Care System
San Antonio, Texas
This program will discuss strategies for the optimal management of COPD and analyze key efficacy and safety data supporting the role of Perforomist Solution in the COPD treatment paradigm. Clinical profiles of patient candidates who may benefit from this treatment will also be presented.
Professor of Medicine
Chief, Division of Pulmonary, Critical Care, and Sleep Medicine
University at Buffalo, State University of New York
Buffalo, New York
This program will discuss the relevant factors that influence the selection of nebulized therapy in the treatment of COPD, including disease severity, patient characteristics, clinical setting, and patient preference.
Distinguished Professor of Medicine
Medical Director, Pulmonary Function Laboratory
David Geffen School of Medicine at UCLA
Los Angeles, California